Global Fosaprepitant Dimeglumine for Injection Market Growth 2025-2031--LP INFORMATION, INC.

Global Fosaprepitant Dimeglumine for Injection Market Growth 2025-2031

Product Code: 1560410

Industry: Pharma & Healthcare

Published: Jun 22,2025

Pages: 116

Delivery Time: 2-3 business days

Global Fosaprepitant Dimeglumine for Injection Market Growth 2025-2031

Product Code: 1560410

Industry: Pharma & Healthcare

Published: Jun 22,2025

Pages: 116

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Fosaprepitant Dimeglumine for Injection market size is predicted to grow from US$ 287 million in 2025 to US$ 452 million in 2031; it is expected to grow at a CAGR of 7.9% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Fosaprepitant dimeglumine is the phosphonate prodrug of aprepitant, which rapidly undergoes hydrolysis in the body to metabolize into aprepitant. It is primarily used to treat nausea and vomiting that occur during highly emetogenic anticancer chemotherapy.

Fosaprepitant Dimeglumine is an intravenous NK-1 receptor antagonist widely used in supportive care for chemotherapy-induced nausea and vomiting (CINV). As standardized oncology treatment protocols become more prevalent globally, the demand for this agent remains stable, with its inclusion in various clinical guidelines reinforcing its role in multi-drug antiemetic regimens.

Following the expiration of primary patents, generic versions of Fosaprepitant have entered key international markets, transitioning the landscape from originator-dominated to generic-driven. In major regions such as North America, Europe, and parts of Asia, a competitive environment has formed among generic manufacturers. Additionally, there is a clear industry trend toward reformulation—from traditional lyophilized powder vials to ready-to-use (RTU) liquid injections—driven by the need for enhanced hospital efficiency and administration safety.

Upstream, the API manufacturing process for Fosaprepitant Dimeglumine is relatively mature, involving phosphoramide-based intermediates with moderate technical barriers. Key API producers are primarily located in China and India, supported by cost advantages and scalable capacity. Downstream, injectable formulation production requires sterile manufacturing capabilities and regulatory experience, particularly for advanced dosage forms like RTU solutions, which require robust stability and quality control measures.

Looking ahead, the global market for Fosaprepitant is expected to maintain modest growth, with increasing concentration among leading generic manufacturers. Key competitive drivers will include formulation innovation, regulatory compliance (especially in international markets), and consistency in quality standards. Companies that can differentiate through advanced delivery forms, international filings, and vertically integrated capabilities are likely to gain a strategic edge in both domestic and export markets.

LP Information, Inc. (LPI) ' newest research report, the “Fosaprepitant Dimeglumine for Injection Industry Forecast” looks at past sales and reviews total world Fosaprepitant Dimeglumine for Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Fosaprepitant Dimeglumine for Injection sales for 2025 through 2031. With Fosaprepitant Dimeglumine for Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fosaprepitant Dimeglumine for Injection industry.

This Insight Report provides a comprehensive analysis of the global Fosaprepitant Dimeglumine for Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Fosaprepitant Dimeglumine for Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Fosaprepitant Dimeglumine for Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fosaprepitant Dimeglumine for Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fosaprepitant Dimeglumine for Injection.

This report presents a comprehensive overview, market shares, and growth opportunities of Fosaprepitant Dimeglumine for Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Original Drug

    Generic Drug

Segmentation by Application:

    Hospital

    Specialty Clinic

This report also splits the market by region:

    Americas

    United States

    Canada

    Mexico

    Brazil

    APAC

    China

    Japan

    Korea

    Southeast Asia

    India

    Australia

    Europe

    Germany

    France

UK

    Italy

    Russia

    Middle East & Africa

    Egypt

    South Africa

    Israel

    Turkey

    GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    Merck

    Fresenius Kabi

    Apotex

    Amneal

    Torrent Pharmaceuticals

    Aark Pharmaceuticals

    Chia Tai Tianqing Pharmaceutical

    Qilu Pharmaceutical

    Yichang Humanwell Pharmaceutical

    Hansoh Pharma

    Luoxin Pharmaceutical

    Aosaikang Pharmaceutical

    Jiuyuan Gene Engineering

Key Questions Addressed in this Report

What is the 10-year outlook for the global Fosaprepitant Dimeglumine for Injection market?

What factors are driving Fosaprepitant Dimeglumine for Injection market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Fosaprepitant Dimeglumine for Injection market opportunities vary by end market size?

How does Fosaprepitant Dimeglumine for Injection break out by Type, by Application?

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Fosaprepitant Dimeglumine for Injection Annual Sales 2020-2031
        2.1.2 World Current & Future Analysis for Fosaprepitant Dimeglumine for Injection by Geographic Region, 2020, 2024 & 2031
        2.1.3 World Current & Future Analysis for Fosaprepitant Dimeglumine for Injection by Country/Region, 2020, 2024 & 2031
    2.2 Fosaprepitant Dimeglumine for Injection Segment by Type
        2.2.1 Original Drug
        2.2.2 Generic Drug
    2.3 Fosaprepitant Dimeglumine for Injection Sales by Type
        2.3.1 Global Fosaprepitant Dimeglumine for Injection Sales Market Share by Type (2020-2025)
        2.3.2 Global Fosaprepitant Dimeglumine for Injection Revenue and Market Share by Type (2020-2025)
        2.3.3 Global Fosaprepitant Dimeglumine for Injection Sale Price by Type (2020-2025)
    2.4 Fosaprepitant Dimeglumine for Injection Segment by Application
        2.4.1 Hospital
        2.4.2 Specialty Clinic
    2.5 Fosaprepitant Dimeglumine for Injection Sales by Application
        2.5.1 Global Fosaprepitant Dimeglumine for Injection Sale Market Share by Application (2020-2025)
        2.5.2 Global Fosaprepitant Dimeglumine for Injection Revenue and Market Share by Application (2020-2025)
        2.5.3 Global Fosaprepitant Dimeglumine for Injection Sale Price by Application (2020-2025)

3 Global by Company
    3.1 Global Fosaprepitant Dimeglumine for Injection Breakdown Data by Company
        3.1.1 Global Fosaprepitant Dimeglumine for Injection Annual Sales by Company (2020-2025)
        3.1.2 Global Fosaprepitant Dimeglumine for Injection Sales Market Share by Company (2020-2025)
    3.2 Global Fosaprepitant Dimeglumine for Injection Annual Revenue by Company (2020-2025)
        3.2.1 Global Fosaprepitant Dimeglumine for Injection Revenue by Company (2020-2025)
        3.2.2 Global Fosaprepitant Dimeglumine for Injection Revenue Market Share by Company (2020-2025)
    3.3 Global Fosaprepitant Dimeglumine for Injection Sale Price by Company
    3.4 Key Manufacturers Fosaprepitant Dimeglumine for Injection Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Fosaprepitant Dimeglumine for Injection Product Location Distribution
        3.4.2 Players Fosaprepitant Dimeglumine for Injection Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.6 New Products and Potential Entrants
    3.7 Market M&A Activity & Strategy

4 World Historic Review for Fosaprepitant Dimeglumine for Injection by Geographic Region
    4.1 World Historic Fosaprepitant Dimeglumine for Injection Market Size by Geographic Region (2020-2025)
        4.1.1 Global Fosaprepitant Dimeglumine for Injection Annual Sales by Geographic Region (2020-2025)
        4.1.2 Global Fosaprepitant Dimeglumine for Injection Annual Revenue by Geographic Region (2020-2025)
    4.2 World Historic Fosaprepitant Dimeglumine for Injection Market Size by Country/Region (2020-2025)
        4.2.1 Global Fosaprepitant Dimeglumine for Injection Annual Sales by Country/Region (2020-2025)
        4.2.2 Global Fosaprepitant Dimeglumine for Injection Annual Revenue by Country/Region (2020-2025)
    4.3 Americas Fosaprepitant Dimeglumine for Injection Sales Growth
    4.4 APAC Fosaprepitant Dimeglumine for Injection Sales Growth
    4.5 Europe Fosaprepitant Dimeglumine for Injection Sales Growth
    4.6 Middle East & Africa Fosaprepitant Dimeglumine for Injection Sales Growth

5 Americas
    5.1 Americas Fosaprepitant Dimeglumine for Injection Sales by Country
        5.1.1 Americas Fosaprepitant Dimeglumine for Injection Sales by Country (2020-2025)
        5.1.2 Americas Fosaprepitant Dimeglumine for Injection Revenue by Country (2020-2025)
    5.2 Americas Fosaprepitant Dimeglumine for Injection Sales by Type (2020-2025)
    5.3 Americas Fosaprepitant Dimeglumine for Injection Sales by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Fosaprepitant Dimeglumine for Injection Sales by Region
        6.1.1 APAC Fosaprepitant Dimeglumine for Injection Sales by Region (2020-2025)
        6.1.2 APAC Fosaprepitant Dimeglumine for Injection Revenue by Region (2020-2025)
    6.2 APAC Fosaprepitant Dimeglumine for Injection Sales by Type (2020-2025)
    6.3 APAC Fosaprepitant Dimeglumine for Injection Sales by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan

7 Europe
    7.1 Europe Fosaprepitant Dimeglumine for Injection by Country
        7.1.1 Europe Fosaprepitant Dimeglumine for Injection Sales by Country (2020-2025)
        7.1.2 Europe Fosaprepitant Dimeglumine for Injection Revenue by Country (2020-2025)
    7.2 Europe Fosaprepitant Dimeglumine for Injection Sales by Type (2020-2025)
    7.3 Europe Fosaprepitant Dimeglumine for Injection Sales by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Fosaprepitant Dimeglumine for Injection by Country
        8.1.1 Middle East & Africa Fosaprepitant Dimeglumine for Injection Sales by Country (2020-2025)
        8.1.2 Middle East & Africa Fosaprepitant Dimeglumine for Injection Revenue by Country (2020-2025)
    8.2 Middle East & Africa Fosaprepitant Dimeglumine for Injection Sales by Type (2020-2025)
    8.3 Middle East & Africa Fosaprepitant Dimeglumine for Injection Sales by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Fosaprepitant Dimeglumine for Injection
    10.3 Manufacturing Process Analysis of Fosaprepitant Dimeglumine for Injection
    10.4 Industry Chain Structure of Fosaprepitant Dimeglumine for Injection

11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Fosaprepitant Dimeglumine for Injection Distributors
    11.3 Fosaprepitant Dimeglumine for Injection Customer

12 World Forecast Review for Fosaprepitant Dimeglumine for Injection by Geographic Region
    12.1 Global Fosaprepitant Dimeglumine for Injection Market Size Forecast by Region
        12.1.1 Global Fosaprepitant Dimeglumine for Injection Forecast by Region (2026-2031)
        12.1.2 Global Fosaprepitant Dimeglumine for Injection Annual Revenue Forecast by Region (2026-2031)
    12.2 Americas Forecast by Country (2026-2031)
    12.3 APAC Forecast by Region (2026-2031)
    12.4 Europe Forecast by Country (2026-2031)
    12.5 Middle East & Africa Forecast by Country (2026-2031)
    12.6 Global Fosaprepitant Dimeglumine for Injection Forecast by Type (2026-2031)
    12.7 Global Fosaprepitant Dimeglumine for Injection Forecast by Application (2026-2031)

13 Key Players Analysis
    13.1 Merck
        13.1.1 Merck Company Information
        13.1.2 Merck Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
        13.1.3 Merck Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
        13.1.4 Merck Main Business Overview
        13.1.5 Merck Latest Developments
    13.2 Fresenius Kabi
        13.2.1 Fresenius Kabi Company Information
        13.2.2 Fresenius Kabi Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
        13.2.3 Fresenius Kabi Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
        13.2.4 Fresenius Kabi Main Business Overview
        13.2.5 Fresenius Kabi Latest Developments
    13.3 Apotex
        13.3.1 Apotex Company Information
        13.3.2 Apotex Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
        13.3.3 Apotex Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
        13.3.4 Apotex Main Business Overview
        13.3.5 Apotex Latest Developments
    13.4 Amneal
        13.4.1 Amneal Company Information
        13.4.2 Amneal Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
        13.4.3 Amneal Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
        13.4.4 Amneal Main Business Overview
        13.4.5 Amneal Latest Developments
    13.5 Torrent Pharmaceuticals
        13.5.1 Torrent Pharmaceuticals Company Information
        13.5.2 Torrent Pharmaceuticals Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
        13.5.3 Torrent Pharmaceuticals Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
        13.5.4 Torrent Pharmaceuticals Main Business Overview
        13.5.5 Torrent Pharmaceuticals Latest Developments
    13.6 Aark Pharmaceuticals
        13.6.1 Aark Pharmaceuticals Company Information
        13.6.2 Aark Pharmaceuticals Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
        13.6.3 Aark Pharmaceuticals Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
        13.6.4 Aark Pharmaceuticals Main Business Overview
        13.6.5 Aark Pharmaceuticals Latest Developments
    13.7 Chia Tai Tianqing Pharmaceutical
        13.7.1 Chia Tai Tianqing Pharmaceutical Company Information
        13.7.2 Chia Tai Tianqing Pharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
        13.7.3 Chia Tai Tianqing Pharmaceutical Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
        13.7.4 Chia Tai Tianqing Pharmaceutical Main Business Overview
        13.7.5 Chia Tai Tianqing Pharmaceutical Latest Developments
    13.8 Qilu Pharmaceutical
        13.8.1 Qilu Pharmaceutical Company Information
        13.8.2 Qilu Pharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
        13.8.3 Qilu Pharmaceutical Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
        13.8.4 Qilu Pharmaceutical Main Business Overview
        13.8.5 Qilu Pharmaceutical Latest Developments
    13.9 Yichang Humanwell Pharmaceutical
        13.9.1 Yichang Humanwell Pharmaceutical Company Information
        13.9.2 Yichang Humanwell Pharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
        13.9.3 Yichang Humanwell Pharmaceutical Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
        13.9.4 Yichang Humanwell Pharmaceutical Main Business Overview
        13.9.5 Yichang Humanwell Pharmaceutical Latest Developments
    13.10 Hansoh Pharma
        13.10.1 Hansoh Pharma Company Information
        13.10.2 Hansoh Pharma Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
        13.10.3 Hansoh Pharma Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
        13.10.4 Hansoh Pharma Main Business Overview
        13.10.5 Hansoh Pharma Latest Developments
    13.11 Luoxin Pharmaceutical
        13.11.1 Luoxin Pharmaceutical Company Information
        13.11.2 Luoxin Pharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
        13.11.3 Luoxin Pharmaceutical Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
        13.11.4 Luoxin Pharmaceutical Main Business Overview
        13.11.5 Luoxin Pharmaceutical Latest Developments
    13.12 Aosaikang Pharmaceutical
        13.12.1 Aosaikang Pharmaceutical Company Information
        13.12.2 Aosaikang Pharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
        13.12.3 Aosaikang Pharmaceutical Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
        13.12.4 Aosaikang Pharmaceutical Main Business Overview
        13.12.5 Aosaikang Pharmaceutical Latest Developments
    13.13 Jiuyuan Gene Engineering
        13.13.1 Jiuyuan Gene Engineering Company Information
        13.13.2 Jiuyuan Gene Engineering Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
        13.13.3 Jiuyuan Gene Engineering Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
        13.13.4 Jiuyuan Gene Engineering Main Business Overview
        13.13.5 Jiuyuan Gene Engineering Latest Developments

14 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Fosaprepitant Dimeglumine for Injection Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Table 2. Fosaprepitant Dimeglumine for Injection Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of Original Drug
 Table 4. Major Players of Generic Drug
 Table 5. Global Fosaprepitant Dimeglumine for Injection Sales by Type (2020-2025) & (Units)
 Table 6. Global Fosaprepitant Dimeglumine for Injection Sales Market Share by Type (2020-2025)
 Table 7. Global Fosaprepitant Dimeglumine for Injection Revenue by Type (2020-2025) & ($ million)
 Table 8. Global Fosaprepitant Dimeglumine for Injection Revenue Market Share by Type (2020-2025)
 Table 9. Global Fosaprepitant Dimeglumine for Injection Sale Price by Type (2020-2025) & (US$/Unit)
 Table 10. Global Fosaprepitant Dimeglumine for Injection Sale by Application (2020-2025) & (Units)
 Table 11. Global Fosaprepitant Dimeglumine for Injection Sale Market Share by Application (2020-2025)
 Table 12. Global Fosaprepitant Dimeglumine for Injection Revenue by Application (2020-2025) & ($ million)
 Table 13. Global Fosaprepitant Dimeglumine for Injection Revenue Market Share by Application (2020-2025)
 Table 14. Global Fosaprepitant Dimeglumine for Injection Sale Price by Application (2020-2025) & (US$/Unit)
 Table 15. Global Fosaprepitant Dimeglumine for Injection Sales by Company (2020-2025) & (Units)
 Table 16. Global Fosaprepitant Dimeglumine for Injection Sales Market Share by Company (2020-2025)
 Table 17. Global Fosaprepitant Dimeglumine for Injection Revenue by Company (2020-2025) & ($ millions)
 Table 18. Global Fosaprepitant Dimeglumine for Injection Revenue Market Share by Company (2020-2025)
 Table 19. Global Fosaprepitant Dimeglumine for Injection Sale Price by Company (2020-2025) & (US$/Unit)
 Table 20. Key Manufacturers Fosaprepitant Dimeglumine for Injection Producing Area Distribution and Sales Area
 Table 21. Players Fosaprepitant Dimeglumine for Injection Products Offered
 Table 22. Fosaprepitant Dimeglumine for Injection Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 23. New Products and Potential Entrants
 Table 24. Market M&A Activity & Strategy
 Table 25. Global Fosaprepitant Dimeglumine for Injection Sales by Geographic Region (2020-2025) & (Units)
 Table 26. Global Fosaprepitant Dimeglumine for Injection Sales Market Share Geographic Region (2020-2025)
 Table 27. Global Fosaprepitant Dimeglumine for Injection Revenue by Geographic Region (2020-2025) & ($ millions)
 Table 28. Global Fosaprepitant Dimeglumine for Injection Revenue Market Share by Geographic Region (2020-2025)
 Table 29. Global Fosaprepitant Dimeglumine for Injection Sales by Country/Region (2020-2025) & (Units)
 Table 30. Global Fosaprepitant Dimeglumine for Injection Sales Market Share by Country/Region (2020-2025)
 Table 31. Global Fosaprepitant Dimeglumine for Injection Revenue by Country/Region (2020-2025) & ($ millions)
 Table 32. Global Fosaprepitant Dimeglumine for Injection Revenue Market Share by Country/Region (2020-2025)
 Table 33. Americas Fosaprepitant Dimeglumine for Injection Sales by Country (2020-2025) & (Units)
 Table 34. Americas Fosaprepitant Dimeglumine for Injection Sales Market Share by Country (2020-2025)
 Table 35. Americas Fosaprepitant Dimeglumine for Injection Revenue by Country (2020-2025) & ($ millions)
 Table 36. Americas Fosaprepitant Dimeglumine for Injection Sales by Type (2020-2025) & (Units)
 Table 37. Americas Fosaprepitant Dimeglumine for Injection Sales by Application (2020-2025) & (Units)
 Table 38. APAC Fosaprepitant Dimeglumine for Injection Sales by Region (2020-2025) & (Units)
 Table 39. APAC Fosaprepitant Dimeglumine for Injection Sales Market Share by Region (2020-2025)
 Table 40. APAC Fosaprepitant Dimeglumine for Injection Revenue by Region (2020-2025) & ($ millions)
 Table 41. APAC Fosaprepitant Dimeglumine for Injection Sales by Type (2020-2025) & (Units)
 Table 42. APAC Fosaprepitant Dimeglumine for Injection Sales by Application (2020-2025) & (Units)
 Table 43. Europe Fosaprepitant Dimeglumine for Injection Sales by Country (2020-2025) & (Units)
 Table 44. Europe Fosaprepitant Dimeglumine for Injection Revenue by Country (2020-2025) & ($ millions)
 Table 45. Europe Fosaprepitant Dimeglumine for Injection Sales by Type (2020-2025) & (Units)
 Table 46. Europe Fosaprepitant Dimeglumine for Injection Sales by Application (2020-2025) & (Units)
 Table 47. Middle East & Africa Fosaprepitant Dimeglumine for Injection Sales by Country (2020-2025) & (Units)
 Table 48. Middle East & Africa Fosaprepitant Dimeglumine for Injection Revenue Market Share by Country (2020-2025)
 Table 49. Middle East & Africa Fosaprepitant Dimeglumine for Injection Sales by Type (2020-2025) & (Units)
 Table 50. Middle East & Africa Fosaprepitant Dimeglumine for Injection Sales by Application (2020-2025) & (Units)
 Table 51. Key Market Drivers & Growth Opportunities of Fosaprepitant Dimeglumine for Injection
 Table 52. Key Market Challenges & Risks of Fosaprepitant Dimeglumine for Injection
 Table 53. Key Industry Trends of Fosaprepitant Dimeglumine for Injection
 Table 54. Fosaprepitant Dimeglumine for Injection Raw Material
 Table 55. Key Suppliers of Raw Materials
 Table 56. Fosaprepitant Dimeglumine for Injection Distributors List
 Table 57. Fosaprepitant Dimeglumine for Injection Customer List
 Table 58. Global Fosaprepitant Dimeglumine for Injection Sales Forecast by Region (2026-2031) & (Units)
 Table 59. Global Fosaprepitant Dimeglumine for Injection Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 60. Americas Fosaprepitant Dimeglumine for Injection Sales Forecast by Country (2026-2031) & (Units)
 Table 61. Americas Fosaprepitant Dimeglumine for Injection Annual Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 62. APAC Fosaprepitant Dimeglumine for Injection Sales Forecast by Region (2026-2031) & (Units)
 Table 63. APAC Fosaprepitant Dimeglumine for Injection Annual Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 64. Europe Fosaprepitant Dimeglumine for Injection Sales Forecast by Country (2026-2031) & (Units)
 Table 65. Europe Fosaprepitant Dimeglumine for Injection Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 66. Middle East & Africa Fosaprepitant Dimeglumine for Injection Sales Forecast by Country (2026-2031) & (Units)
 Table 67. Middle East & Africa Fosaprepitant Dimeglumine for Injection Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 68. Global Fosaprepitant Dimeglumine for Injection Sales Forecast by Type (2026-2031) & (Units)
 Table 69. Global Fosaprepitant Dimeglumine for Injection Revenue Forecast by Type (2026-2031) & ($ millions)
 Table 70. Global Fosaprepitant Dimeglumine for Injection Sales Forecast by Application (2026-2031) & (Units)
 Table 71. Global Fosaprepitant Dimeglumine for Injection Revenue Forecast by Application (2026-2031) & ($ millions)
 Table 72. Merck Basic Information, Fosaprepitant Dimeglumine for Injection Manufacturing Base, Sales Area and Its Competitors
 Table 73. Merck Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
 Table 74. Merck Fosaprepitant Dimeglumine for Injection Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 75. Merck Main Business
 Table 76. Merck Latest Developments
 Table 77. Fresenius Kabi Basic Information, Fosaprepitant Dimeglumine for Injection Manufacturing Base, Sales Area and Its Competitors
 Table 78. Fresenius Kabi Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
 Table 79. Fresenius Kabi Fosaprepitant Dimeglumine for Injection Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 80. Fresenius Kabi Main Business
 Table 81. Fresenius Kabi Latest Developments
 Table 82. Apotex Basic Information, Fosaprepitant Dimeglumine for Injection Manufacturing Base, Sales Area and Its Competitors
 Table 83. Apotex Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
 Table 84. Apotex Fosaprepitant Dimeglumine for Injection Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 85. Apotex Main Business
 Table 86. Apotex Latest Developments
 Table 87. Amneal Basic Information, Fosaprepitant Dimeglumine for Injection Manufacturing Base, Sales Area and Its Competitors
 Table 88. Amneal Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
 Table 89. Amneal Fosaprepitant Dimeglumine for Injection Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Amneal Main Business
 Table 91. Amneal Latest Developments
 Table 92. Torrent Pharmaceuticals Basic Information, Fosaprepitant Dimeglumine for Injection Manufacturing Base, Sales Area and Its Competitors
 Table 93. Torrent Pharmaceuticals Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
 Table 94. Torrent Pharmaceuticals Fosaprepitant Dimeglumine for Injection Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 95. Torrent Pharmaceuticals Main Business
 Table 96. Torrent Pharmaceuticals Latest Developments
 Table 97. Aark Pharmaceuticals Basic Information, Fosaprepitant Dimeglumine for Injection Manufacturing Base, Sales Area and Its Competitors
 Table 98. Aark Pharmaceuticals Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
 Table 99. Aark Pharmaceuticals Fosaprepitant Dimeglumine for Injection Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 100. Aark Pharmaceuticals Main Business
 Table 101. Aark Pharmaceuticals Latest Developments
 Table 102. Chia Tai Tianqing Pharmaceutical Basic Information, Fosaprepitant Dimeglumine for Injection Manufacturing Base, Sales Area and Its Competitors
 Table 103. Chia Tai Tianqing Pharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
 Table 104. Chia Tai Tianqing Pharmaceutical Fosaprepitant Dimeglumine for Injection Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 105. Chia Tai Tianqing Pharmaceutical Main Business
 Table 106. Chia Tai Tianqing Pharmaceutical Latest Developments
 Table 107. Qilu Pharmaceutical Basic Information, Fosaprepitant Dimeglumine for Injection Manufacturing Base, Sales Area and Its Competitors
 Table 108. Qilu Pharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
 Table 109. Qilu Pharmaceutical Fosaprepitant Dimeglumine for Injection Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 110. Qilu Pharmaceutical Main Business
 Table 111. Qilu Pharmaceutical Latest Developments
 Table 112. Yichang Humanwell Pharmaceutical Basic Information, Fosaprepitant Dimeglumine for Injection Manufacturing Base, Sales Area and Its Competitors
 Table 113. Yichang Humanwell Pharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
 Table 114. Yichang Humanwell Pharmaceutical Fosaprepitant Dimeglumine for Injection Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 115. Yichang Humanwell Pharmaceutical Main Business
 Table 116. Yichang Humanwell Pharmaceutical Latest Developments
 Table 117. Hansoh Pharma Basic Information, Fosaprepitant Dimeglumine for Injection Manufacturing Base, Sales Area and Its Competitors
 Table 118. Hansoh Pharma Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
 Table 119. Hansoh Pharma Fosaprepitant Dimeglumine for Injection Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 120. Hansoh Pharma Main Business
 Table 121. Hansoh Pharma Latest Developments
 Table 122. Luoxin Pharmaceutical Basic Information, Fosaprepitant Dimeglumine for Injection Manufacturing Base, Sales Area and Its Competitors
 Table 123. Luoxin Pharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
 Table 124. Luoxin Pharmaceutical Fosaprepitant Dimeglumine for Injection Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 125. Luoxin Pharmaceutical Main Business
 Table 126. Luoxin Pharmaceutical Latest Developments
 Table 127. Aosaikang Pharmaceutical Basic Information, Fosaprepitant Dimeglumine for Injection Manufacturing Base, Sales Area and Its Competitors
 Table 128. Aosaikang Pharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
 Table 129. Aosaikang Pharmaceutical Fosaprepitant Dimeglumine for Injection Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 130. Aosaikang Pharmaceutical Main Business
 Table 131. Aosaikang Pharmaceutical Latest Developments
 Table 132. Jiuyuan Gene Engineering Basic Information, Fosaprepitant Dimeglumine for Injection Manufacturing Base, Sales Area and Its Competitors
 Table 133. Jiuyuan Gene Engineering Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications
 Table 134. Jiuyuan Gene Engineering Fosaprepitant Dimeglumine for Injection Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 135. Jiuyuan Gene Engineering Main Business
 Table 136. Jiuyuan Gene Engineering Latest Developments


List of Figures
 Figure 1. Picture of Fosaprepitant Dimeglumine for Injection
 Figure 2. Fosaprepitant Dimeglumine for Injection Report Years Considered
 Figure 3. Research Objectives
 Figure 4. Research Methodology
 Figure 5. Research Process and Data Source
 Figure 6. Global Fosaprepitant Dimeglumine for Injection Sales Growth Rate 2020-2031 (Units)
 Figure 7. Global Fosaprepitant Dimeglumine for Injection Revenue Growth Rate 2020-2031 ($ millions)
 Figure 8. Fosaprepitant Dimeglumine for Injection Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 9. Fosaprepitant Dimeglumine for Injection Sales Market Share by Country/Region (2024)
 Figure 10. Fosaprepitant Dimeglumine for Injection Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 11. Product Picture of Original Drug
 Figure 12. Product Picture of Generic Drug
 Figure 13. Global Fosaprepitant Dimeglumine for Injection Sales Market Share by Type in 2025
 Figure 14. Global Fosaprepitant Dimeglumine for Injection Revenue Market Share by Type (2020-2025)
 Figure 15. Fosaprepitant Dimeglumine for Injection Consumed in Hospital
 Figure 16. Global Fosaprepitant Dimeglumine for Injection Market: Hospital (2020-2025) & (Units)
 Figure 17. Fosaprepitant Dimeglumine for Injection Consumed in Specialty Clinic
 Figure 18. Global Fosaprepitant Dimeglumine for Injection Market: Specialty Clinic (2020-2025) & (Units)
 Figure 19. Global Fosaprepitant Dimeglumine for Injection Sale Market Share by Application (2024)
 Figure 20. Global Fosaprepitant Dimeglumine for Injection Revenue Market Share by Application in 2025
 Figure 21. Fosaprepitant Dimeglumine for Injection Sales by Company in 2025 (Units)
 Figure 22. Global Fosaprepitant Dimeglumine for Injection Sales Market Share by Company in 2025
 Figure 23. Fosaprepitant Dimeglumine for Injection Revenue by Company in 2025 ($ millions)
 Figure 24. Global Fosaprepitant Dimeglumine for Injection Revenue Market Share by Company in 2025
 Figure 25. Global Fosaprepitant Dimeglumine for Injection Sales Market Share by Geographic Region (2020-2025)
 Figure 26. Global Fosaprepitant Dimeglumine for Injection Revenue Market Share by Geographic Region in 2025
 Figure 27. Americas Fosaprepitant Dimeglumine for Injection Sales 2020-2025 (Units)
 Figure 28. Americas Fosaprepitant Dimeglumine for Injection Revenue 2020-2025 ($ millions)
 Figure 29. APAC Fosaprepitant Dimeglumine for Injection Sales 2020-2025 (Units)
 Figure 30. APAC Fosaprepitant Dimeglumine for Injection Revenue 2020-2025 ($ millions)
 Figure 31. Europe Fosaprepitant Dimeglumine for Injection Sales 2020-2025 (Units)
 Figure 32. Europe Fosaprepitant Dimeglumine for Injection Revenue 2020-2025 ($ millions)
 Figure 33. Middle East & Africa Fosaprepitant Dimeglumine for Injection Sales 2020-2025 (Units)
 Figure 34. Middle East & Africa Fosaprepitant Dimeglumine for Injection Revenue 2020-2025 ($ millions)
 Figure 35. Americas Fosaprepitant Dimeglumine for Injection Sales Market Share by Country in 2025
 Figure 36. Americas Fosaprepitant Dimeglumine for Injection Revenue Market Share by Country (2020-2025)
 Figure 37. Americas Fosaprepitant Dimeglumine for Injection Sales Market Share by Type (2020-2025)
 Figure 38. Americas Fosaprepitant Dimeglumine for Injection Sales Market Share by Application (2020-2025)
 Figure 39. United States Fosaprepitant Dimeglumine for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 40. Canada Fosaprepitant Dimeglumine for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 41. Mexico Fosaprepitant Dimeglumine for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 42. Brazil Fosaprepitant Dimeglumine for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 43. APAC Fosaprepitant Dimeglumine for Injection Sales Market Share by Region in 2025
 Figure 44. APAC Fosaprepitant Dimeglumine for Injection Revenue Market Share by Region (2020-2025)
 Figure 45. APAC Fosaprepitant Dimeglumine for Injection Sales Market Share by Type (2020-2025)
 Figure 46. APAC Fosaprepitant Dimeglumine for Injection Sales Market Share by Application (2020-2025)
 Figure 47. China Fosaprepitant Dimeglumine for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 48. Japan Fosaprepitant Dimeglumine for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 49. South Korea Fosaprepitant Dimeglumine for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 50. Southeast Asia Fosaprepitant Dimeglumine for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 51. India Fosaprepitant Dimeglumine for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 52. Australia Fosaprepitant Dimeglumine for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 53. China Taiwan Fosaprepitant Dimeglumine for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 54. Europe Fosaprepitant Dimeglumine for Injection Sales Market Share by Country in 2025
 Figure 55. Europe Fosaprepitant Dimeglumine for Injection Revenue Market Share by Country (2020-2025)
 Figure 56. Europe Fosaprepitant Dimeglumine for Injection Sales Market Share by Type (2020-2025)
 Figure 57. Europe Fosaprepitant Dimeglumine for Injection Sales Market Share by Application (2020-2025)
 Figure 58. Germany Fosaprepitant Dimeglumine for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 59. France Fosaprepitant Dimeglumine for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 60. UK Fosaprepitant Dimeglumine for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 61. Italy Fosaprepitant Dimeglumine for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 62. Russia Fosaprepitant Dimeglumine for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 63. Middle East & Africa Fosaprepitant Dimeglumine for Injection Sales Market Share by Country (2020-2025)
 Figure 64. Middle East & Africa Fosaprepitant Dimeglumine for Injection Sales Market Share by Type (2020-2025)
 Figure 65. Middle East & Africa Fosaprepitant Dimeglumine for Injection Sales Market Share by Application (2020-2025)
 Figure 66. Egypt Fosaprepitant Dimeglumine for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 67. South Africa Fosaprepitant Dimeglumine for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 68. Israel Fosaprepitant Dimeglumine for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 69. Turkey Fosaprepitant Dimeglumine for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 70. GCC Countries Fosaprepitant Dimeglumine for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 71. Manufacturing Cost Structure Analysis of Fosaprepitant Dimeglumine for Injection in 2025
 Figure 72. Manufacturing Process Analysis of Fosaprepitant Dimeglumine for Injection
 Figure 73. Industry Chain Structure of Fosaprepitant Dimeglumine for Injection
 Figure 74. Channels of Distribution
 Figure 75. Global Fosaprepitant Dimeglumine for Injection Sales Market Forecast by Region (2026-2031)
 Figure 76. Global Fosaprepitant Dimeglumine for Injection Revenue Market Share Forecast by Region (2026-2031)
 Figure 77. Global Fosaprepitant Dimeglumine for Injection Sales Market Share Forecast by Type (2026-2031)
 Figure 78. Global Fosaprepitant Dimeglumine for Injection Revenue Market Share Forecast by Type (2026-2031)
 Figure 79. Global Fosaprepitant Dimeglumine for Injection Sales Market Share Forecast by Application (2026-2031)
 Figure 80. Global Fosaprepitant Dimeglumine for Injection Revenue Market Share Forecast by Application (2026-2031)

Companies Mentioned

Merck

Fresenius Kabi

Apotex

Amneal

Torrent Pharmaceuticals

Aark Pharmaceuticals

Chia Tai Tianqing Pharmaceutical

Qilu Pharmaceutical

Yichang Humanwell Pharmaceutical

Hansoh Pharma

Luoxin Pharmaceutical

Aosaikang Pharmaceutical

Jiuyuan Gene Engineering

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff